290 related articles for article (PubMed ID: 24975947)
1. Photodynamic therapy for the treatment of microinvasive squamous cell carcinoma of the lower lip: a case report.
Fargnoli MC; Kostaki D; Piccioni A; Di Stefani A; Peris K
G Ital Dermatol Venereol; 2015 Jun; 150(3):331-5. PubMed ID: 24975947
[TBL] [Abstract][Full Text] [Related]
2. Effect of Methyl Aminolevulinate Photodynamic Therapy With and Without Ablative Fractional Laser Treatment in Patients With Microinvasive Squamous Cell Carcinoma: A Randomized Clinical Trial.
Choi SH; Kim KH; Song KH
JAMA Dermatol; 2017 Mar; 153(3):289-295. PubMed ID: 28199463
[TBL] [Abstract][Full Text] [Related]
3. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma.
Calzavara-Pinton PG; Venturini M; Sala R; Capezzera R; Parrinello G; Specchia C; Zane C
Br J Dermatol; 2008 Jul; 159(1):137-44. PubMed ID: 18489606
[TBL] [Abstract][Full Text] [Related]
4. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy with topical methyl- and hexylaminolevulinate for prophylaxis and treatment of UV-induced SCC in hairless mice.
Togsverd-Bo K; Lerche CM; Poulsen T; Wulf HC; Haedersdal M
Exp Dermatol; 2010 Aug; 19(8):e166-72. PubMed ID: 20100196
[TBL] [Abstract][Full Text] [Related]
6. Interventions for cutaneous Bowen's disease.
Bath-Hextall FJ; Matin RN; Wilkinson D; Leonardi-Bee J
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD007281. PubMed ID: 23794286
[TBL] [Abstract][Full Text] [Related]
7. A retrospective analysis of real-life practice of off-label photodynamic therapy using methyl aminolevulinate (MAL-PDT) in 20 Italian dermatology departments. Part 2: oncologic and infectious indications.
Calzavara-Pinton PG; Rossi MT; Sala R;
Photochem Photobiol Sci; 2013 Jan; 12(1):158-65. PubMed ID: 22949076
[TBL] [Abstract][Full Text] [Related]
8. Current methods for photodynamic therapy in the US: comparison of MAL/PDT and ALA/PDT.
Lee PK; Kloser A
J Drugs Dermatol; 2013 Aug; 12(8):925-30. PubMed ID: 23986167
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of ablative fractional laser-assisted photodynamic therapy for the treatment of actinic cheilitis: 12-month follow-up results of a prospective, randomized, comparative trial.
Choi SH; Kim KH; Song KH
Br J Dermatol; 2015 Jul; 173(1):184-91. PubMed ID: 25400009
[TBL] [Abstract][Full Text] [Related]
10. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up.
Szeimies RM; Ibbotson S; Murrell DF; Rubel D; Frambach Y; de Berker D; Dummer R; Kerrouche N; Villemagne H;
J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1302-11. PubMed ID: 18624836
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy in the management of actinic keratosis: Retrospective evaluation of outcome.
Jerjes W; Hamdoon Z; Abdulkareem AA; Hopper C
Photodiagnosis Photodyn Ther; 2017 Mar; 17():200-204. PubMed ID: 27174210
[TBL] [Abstract][Full Text] [Related]
12. Aminolevulinic acid and methyl aminolevulinate equally effective in topical photodynamic therapy for non-melanoma skin cancers.
Tarstedt M; Gillstedt M; Wennberg Larkö AM; Paoli J
J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):420-3. PubMed ID: 26841041
[TBL] [Abstract][Full Text] [Related]
13. Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoma.
Annemans L; Caekelbergh K; Roelandts R; Boonen H; Leys C; Nikkels AF; van Den Haute V; van Quickenborne L; Verhaeghe E; Leroy B
Eur J Dermatol; 2008; 18(5):539-46. PubMed ID: 18693157
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the efficacy of photodynamic therapy for the treatment of actinic cheilitis.
Chaves YN; Torezan LA; Lourenço SV; Neto CF
Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):14-21. PubMed ID: 27864997
[TBL] [Abstract][Full Text] [Related]
15. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic cheilitis: a retrospective evaluation of 29 patients.
Fai D; Romano I; Cassano N; Vena GA
G Ital Dermatol Venereol; 2012 Feb; 147(1):99-101. PubMed ID: 22370573
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy for the treatment of actinic cheilitis.
Kodama M; Watanabe D; Akita Y; Tamada Y; Matsumoto Y
Photodermatol Photoimmunol Photomed; 2007 Oct; 23(5):209-10. PubMed ID: 17803601
[TBL] [Abstract][Full Text] [Related]
17. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
Tyrrell JS; Campbell SM; Curnow A
Lasers Surg Med; 2010 Sep; 42(7):613-9. PubMed ID: 20806386
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma.
Bhatta AK; Wang P; Keyal U; Zhao Z; Ji J; Zhu L; Wang X; Zhang G
Photodiagnosis Photodyn Ther; 2018 Sep; 23():273-280. PubMed ID: 30030167
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial.
Surrenti T; De Angelis L; Di Cesare A; Fargnoli MC; Peris K
Eur J Dermatol; 2007; 17(5):412-5. PubMed ID: 17673385
[TBL] [Abstract][Full Text] [Related]
20. The France-PDT study: a national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-up.
Farhi D; Bedane C; Savary J; Basset-Seguin N
Eur J Dermatol; 2013; 23(1):68-76. PubMed ID: 23400280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
